The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 12, 2024

Filed:

Mar. 01, 2019
Applicant:

Elicio Therapeutics, Inc., Cambridge, MA (US);

Inventors:

Peter C. Demuth, Medford, MA (US);

Julian Adams, Boston, MA (US);

Martin Steinbuck, Boston, MA (US);

Assignee:

Elicio Therapeutics, Inc., Boston, MA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 39/00 (2006.01); A61K 39/39 (2006.01); A61K 47/54 (2017.01); A61K 47/60 (2017.01); A61P 35/00 (2006.01); C07K 7/00 (2006.01); C12N 9/14 (2006.01); C12N 9/96 (2006.01);
U.S. Cl.
CPC ...
A61K 39/001164 (2018.08); A61K 39/39 (2013.01); A61K 47/543 (2017.08); A61K 47/60 (2017.08); A61P 35/00 (2018.01); C12N 9/14 (2013.01); C12N 9/96 (2013.01); C12Y 306/05002 (2013.01); A61K 2039/545 (2013.01); A61K 2039/55561 (2013.01);
Abstract

The invention features a compound including a mutant KRAS sequence and a lipid, where the mutant KRAS sequence is conjugated to the lipid by a linker, and (i) the linker includes one or more polyethylene glycol blocks, (ii) the lipid is 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), and (iii) the mutant KRAS sequence comprises or consists of the amino acid sequence selected from the group consisting of SEQ ID NOs:1-7 and 22-30. The invention features a composition including one or more compounds of the invention and a pharmaceutically acceptable carrier. The invention also features a method of treating a cancer in a human patient, the method including administering the composition to the patient. Further, the invention features a kit comprising the compound.


Find Patent Forward Citations

Loading…